Alnyam Pharmaceuticals (ALNY), which fell after reporting Q4 results last week, is down 4% AH...
Alnyam Pharmaceuticals (ALNY), which fell after reporting Q4 results last week, is down 4% AH after filing to sell 7M shares, worth $86.7M based on today's close. The company, less than a month removed from announcing a major restructuring plan, says it will use the proceeds to help advance its drug pipeline, including its ALN-TTR02 and ALN-APC drugs.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Fri, 9:16AM)
at Nasdaq.com (Jan 23, 2015)
at Benzinga.com (Jan 12, 2015)
at CNBC.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs